Summary:
Attention: Is Your Mild to Moderate Ulcerative Colitis not Adequately Controlled?
If you are age 18 or older, you may qualify for a clinical research study of the safety and
effectiveness of a drug designed to treat ulcerative colitis.
Qualified participants will receive:
- Study-related medicine or placebo at no-cost
- Study-related medical care at no-cost
- Compensation up to $510 for time and travel
Qualified Participants Must:
• Be taking mesalamine for at least six weeks prior to joining the study
•
Have active mild to moderate ulcerative colitis
•
NOT suffer from Crohn’s disease